Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT02955758 · COMPLETED
Trial details
- NCT number
- NCT02955758
- Sponsor
- Joel Neal
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2024-04-09
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.